Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06608758 · ClinicalTrials.gov registry record
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
A clinical trial of Disabilities Multiple, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- 120,000
- Enrollment target
- 1
- Study location
NCT06608758: Recruiting study of Disabilities Multiple, sponsored by Rush University Medical Center.
NCT06608758 is a study of Disabilities Multiple that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 120,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06608758, a study of Disabilities Multiple, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- 120,000 participants
- Enrollment target
- 1
- Study location
Study Summary
People with disabilities (PWD) experience increased risk of diagnostic error-sometimes due to attributing symptoms to disability rather than a potentially new or co-morbid conditions. As well, some diagnoses are prone to error. Based on literature we identified the following twenty-six with ICD-10 codes: Aortic aneurysm and dissection I71.0 - I71.9; Arterial thromboembolism I74.0 - I74.9; Venous thromboembolism I82.0-I82.99 and I82.A-I82.C; Congestive heart failure I50.1-150.9; Stroke All I60, I61, I62, I63, I64; Myocardial infarction I21.0-I21.9 and I21.A-I21.B; Spinal abscess G06.0, G06.1 and G06.2; Meningitis and encephalitis G04 -G04.91; Endocarditis I33.0-I33.9 and I38; Sepsis A41.0-A41.9; Pneumonia J12.0-J95.851; Lung cancer C34.0-C34.92; Melanoma C43.0- C43.9; Colorectal cancer C18.0-C18.9; Breast cancer C50 to C50.929, and C79.81; Prostate cancer C61; Pediatric Arterial ischemic stroke I63.0-163.9xx; Appendicitis K35-K35.8xx; Asthma J45.2-J45.998; Retinal blastoma C69.20, C69.21, C60.22; Brain tumor C71.0-C71.9; Polyateritis M30.0-M30.8; Congenital heart disease Q20 - Q28 (Q24.9 particularly important); Duchense muscular dystrophy G71.0-G71.9; Inflammatory bowel disease K51.0-K51.9; Scleroderma M34.0-M34.9.The goal of this research is to identify and create understanding of what underlies and contributes to increased risk of diagnostic error with these diagnoses. The investigators plan to develop ways to reduce it, specifically ways to identify people with disabilities at risk of diagnostic error (DE). The investigators will also develop education programs and decision supports targeted to healthcare professionals. If it is effective, ways to reduce diagnostic error will have been developed among people with disabilities.
Primary Outcome
After implementation of EHR prompts/alerts and decision supports related to diagnostic error, descriptive data will be collected and analyzed on usage.
Conditions Studied
Interventions
- OTHER Standard of care
- BEHAVIORAL Electonic health record prompts with education
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120,000 participants |
| Start Date | 2024-11-22 |
| Est. Completion | 2029-07-31 |
What NCT06608758 shows while recruiting
NCT06608758 is an observational study that tracks outcomes without assigning an intervention. Its 120,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Disabilities Multiple appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT06608758 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06608758 about?
NCT06608758 is a clinical study titled "End Diagnostic Overshadowing:Addressing Ableism in Diagnoses". People with disabilities (PWD) experience increased risk of diagnostic error-sometimes due to attributing symptoms to disability rather than a potentially new or co-morbid conditions. As well, some diagnoses are prone to error. Based on literature we identified the following twenty-six with ICD-10 c...
What is the current status of trial NCT06608758?
This trial is currently recruiting. The enrollment target is 120,000 participants. The study started on 2024-11-22. Estimated completion is 2029-07-31.
What conditions does trial NCT06608758 study?
This clinical trial studies the following conditions: Disabilities Multiple.
What interventions are being tested in trial NCT06608758?
The interventions under investigation include: Standard of care (OTHER), Electonic health record prompts with education (BEHAVIORAL).
Who is sponsoring clinical trial NCT06608758?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06608758 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disabilities Multiple
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897374 · 120,000 participants
Strategic Targeting for Optimal Prevention of Cancer
- NCT06251323 · 119,680 participants · NA
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI